PTX prescient therapeutics limited

Prescient Therapeutics Shareholder Update

  1. 2,111 Posts.
    lightbulb Created with Sketch. 823
    Looking forward to James presenting the shareholder update today at 1pm


    In this session, I will discuss:
    • What to expect from our Phase 2a trial, with First Patient In and Dosed (FPID) anticipated in the coming weeks.
    • How our promising Phase 1b results could help turn our Phase 2 trial into a registrational study.
    • The significance of the Fast Track Designation granted by the FDA in April, and what it means for our potential accelerated path to commercialisation.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
5.2¢
Change
-0.001(1.89%)
Mkt cap ! $41.87M
Open High Low Value Volume
5.3¢ 5.3¢ 4.9¢ $51.46K 1.024M

Buyers (Bids)

No. Vol. Price($)
1 18678 5.0¢
 

Sellers (Offers)

Price($) Vol. No.
5.2¢ 50000 1
View Market Depth
Last trade - 15.15pm 13/06/2025 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.